Ingen Biosciences appoints Research & Development Director

Dr. Karine Mignon-Godefroy will head Ingen Biosciences’ R&D

12-Jul-2010 - France
Ingen Biosciences announced that the company has appointed Dr. Karine Mignon-Godefroy as director of research & development. Dr. Mignon-Godefroy joins Ingen Biosciences just at the point when the company has launched its first proprietary in vitro diagnostic (IVD) kit, as part of its drive to generate new revenue. Ingen Biosciences posted EUR 20 million revenues in 2009, derived mainly from sales of outsourced products. Dr. Mignon-Godefroy will be responsible for identifying clinically relevant recombinant antigens as potential markers for the detection of infectious diseases found in prosthetic replacements, and to develop innovative IVD kits for clinical use. Dr. Mignon-Godefroy, (43), joins Ingen Biosciences from the Blood Virus division of Bio-Rad, where she was director of international projects for two years. Before Bio-Rad, she held the post of R&D manager at BMD, a developer of biomedical diagnostics from 2002 – 2008, where she was in charge of developing reagents based on Luminex technology. From 1995 to 2001, Dr. Mignon-Godefroy was group leader at Chemunex (known as AES-Chemunex), a company specializing in detecting microbiological contamination. She received her PhD in immunology from the University of Pierre and Marie Curie (Paris).

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances